Login
Toggle sidebar

Lint: egfr-mutation

egfr-mutation
Units
error

"EGFR exon 19 deletion (E19del): considered most common activating mutation in advanced non-small cell lung cancer (NSCLC) 8"

Line 10:39 · Put a space between the number and the unit in '19d'.

"EGFR exon 21 deletion (E21del): considered next most common activating mutation in advanced non-small cell lung cancer (NSCLC) 9"

Line 11:39 · Put a space between the number and the unit in '21d'.
Emphasis
warning

"An epidermal growth factor receptor (EGFR) mutation may be expressed in a large proportion of non-small cell lung carcinomas (NSCLC). However, certain subtypes such as invasive mucinous adenocarcinoma of the lung can have very low expression."

Line 1:49 · Italics should be used only in exceptional circumstances: '<em>EGFR</em>'
Acronyms
warning

"KRAS mutation"

Line 15:11 · 'KRAS' has no definition. Spell it out if it's unfamiliar to the audience.

"HER-2 mutations in lung cancer"

Line 16:11 · 'HER' has no definition. Spell it out if it's unfamiliar to the audience.

"ROS 1 mutation"

Line 18:11 · 'ROS' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Clinical importance"

Line 6:1 · "Clinical importance" is not a recognised heading for this article type.

"Specific types"

Line 8:1 · "Specific types" is not a recognised heading for this article type.
There Is
suggestion

"There is also some (but not 100% 5) mutual exclusivity with ALK gene arrangements."

Line 3:4 · Don't start a sentence with 'There is'.
Parentheses
suggestion

"Useful for assessing the suitability of certain anticancer drugs (tyrosine kinase inhibitors) that inhibit EGFR such as gefitinib (Iressa), erlotinib (Tarceva), and afatinib (Gilotrif) 7."

Line 7:69 · Use parentheses judiciously. There are at least 3 sets in this paragraph.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0